Cargando…
Comparative efficacy and acceptability of licensed dose intranasal corticosteroids for moderate-to-severe allergic rhinitis: a systematic review and network meta-analysis
No evidence shows that one intranasal corticosteroid (INCS) is better than another for treating moderate-to-severe allergic rhinitis (AR). This network meta-analysis assessed the comparative efficacy and acceptability of licensed dose aqueous INCSs. PubMed/MEDLINE, Scopus, EMBASE, and the Cochrane C...
Autores principales: | Soe, Kay Khine, Krikeerati, Thanachit, Pheerapanyawaranun, Chatkamol, Niyomnaitham, Suvimol, Phinyo, Phichayut, Thongngarm, Torpong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242043/ https://www.ncbi.nlm.nih.gov/pubmed/37288109 http://dx.doi.org/10.3389/fphar.2023.1184552 |
Ejemplares similares
-
Successful Deferasirox Rechallenge and Treating Through Reaction in a Patient with Challenge-Proven Mild Immediate Reaction: A Case Report
por: Sompornrattanaphan, Mongkhon, et al.
Publicado: (2020) -
Evaluation of the Safety and Immunogenicity of Fractional Intradermal COVID-19 Vaccines as a Booster: A Pilot Study
por: Niyomnaitham, Suvimol, et al.
Publicado: (2022) -
Not Just a Banana: The Extent of Fruit Cross-Reactivity and Reaction Severity in Adults with Banana Allergy
por: Julanon, Narachai, et al.
Publicado: (2023) -
Patient-rated angioedema severity using a novel photo-aid for predicting non-mast cell mediator-induced angioedema diagnosis
por: Wongsa, Chamard, et al.
Publicado: (2023) -
Overcoming barriers to intranasal corticosteroid use in patients with uncontrolled allergic rhinitis
por: Bridgeman, Mary Barna
Publicado: (2017)